Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
about
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceAs the world grows: contraception in the 21st centuryInsights into cytokine-receptor interactions from cytokine engineeringOptimizing the affinity and specificity of proteins with molecular display.Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins.Non-cell-autonomous stimulation of stem cell proliferation following ablation of Tcf3.Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice.Leukemia inhibitory factor enhances endometrial stromal cell decidualization in humans and miceBlocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy.Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone MassCaspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation.An anti-inflammatory role for leukemia inhibitory factor receptor signaling in regenerating skeletal muscle.
P2860
Q24642117-6188B323-D989-4BE5-A257-F7FF926E8B2BQ24648373-48C7962A-3EDD-47BA-A568-BF8DF7346800Q26852703-6CB30E2C-9A14-4E41-B159-3944CF974279Q33252425-EF53932C-17A1-497E-9BED-EB1FD8797690Q33502518-263BEE93-7F9D-4B25-8B85-B6102C9F2A21Q33712458-33241025-25D9-4860-BA58-8E3BD73356A2Q33911059-F85A7B06-1A6F-40B1-A0C2-8E96D59D4AADQ34038175-22F71649-E9B7-4CB2-B09D-3B74DDC04022Q36288587-CDF3388C-F032-4342-A5BA-9B6596702E18Q42380690-45B0DFA4-3ECE-424C-8FE5-5F663E7F5E5BQ42868701-B758F05A-D911-4698-A6F9-E7C51D781ADBQ45063060-ACC18BC1-53AB-4A72-8868-8CFE47B7187F
P2860
Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Affinity maturation of leukemi ...... tent antagonists of signaling.
@ast
Affinity maturation of leukemi ...... tent antagonists of signaling.
@en
type
label
Affinity maturation of leukemi ...... tent antagonists of signaling.
@ast
Affinity maturation of leukemi ...... tent antagonists of signaling.
@en
prefLabel
Affinity maturation of leukemi ...... tent antagonists of signaling.
@ast
Affinity maturation of leukemi ...... tent antagonists of signaling.
@en
P2093
P2860
P50
P356
P1476
Affinity maturation of leukemi ...... otent antagonists of signaling
@en
P2093
Alessandro D Uboldi
Chunxiao C Wang
Joanne E McCoubrie
Manuel Baca
Raymond S Norton
Sandra Mifsud
P2860
P304
P356
10.1074/JBC.M310103200
P407
P577
2003-10-29T00:00:00Z